Griffin Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Griffin Asset Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-620	Closed	-$233K	–	222
2019 Q4	$233K	Buy	+620	New	+$209K	0.03%	202
2019 Q3	–	Sell	-725	Closed	-$227K	–	423
2019 Q2	$227K	Hold	725	–	–	0.03%	230
2019 Q1	$298K	Hold	725	–	–	0.04%	208
2018 Q4	$271K	Sell	725 -3,763	-84%	-$1.38M	0.05%	195
2018 Q3	$1.81M	Buy	4,488 +320	+8%	+$122K	0.27%	98
2018 Q2	$1.44M	Buy	4,168 +695	+20%	+$217K	0.26%	107
2018 Q1	$1.2M	Buy	3,473 +32	+0.9%	+$11.1K	0.22%	114
2017 Q4	$1.29M	Sell	3,441 -90	-3%	-$36.5K	0.23%	111
2017 Q3	$1.58M	Buy	+3,531	New	+$1.68M	0.29%	95

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Griffin Asset Management's REGN Position: Q1 2020 in Review

Griffin Asset Management sold out of Regeneron Pharmaceuticals (REGN) in Q1 2020, closing a stake of 620 shares — an estimated $233K sold.

Griffin Asset Management first reported a position in REGN in Q3 2017 and held it in 9 quarters. The position peaked at $1.81M in Q3 2018. 816 funds tracked by Wall St. Rank hold REGN as of Q1 2020.

Griffin Asset Management reported no remaining Regeneron Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Griffin Asset Management sold 620 Regeneron Pharmaceuticals shares in Q1 2020, an estimated $233K.
Griffin Asset Management first reported a position in Regeneron Pharmaceuticals in Q3 2017 and held it in 9 quarters.
Griffin Asset Management's Regeneron Pharmaceuticals position peaked at $1.81M in Q3 2018.
816 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2020.

Based on Griffin Asset Management's 13F filing for Q1 2020, filed 18 May 2020.